(Q34725080)

English

Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Orly Weinreb

1 reference

Europe PubMed Central

4 August 2017

Moussa B. H. Youdim

4

object named as

Moussa B H Youdim

1 reference

Europe PubMed Central

4 August 2017

author name string

Tamar Amit

2

1 reference

Europe PubMed Central

4 August 2017

Orit Bar-Am

3

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

4 August 2017

number of pages

14

1 reference

based on heuristic

inferred from page(s)

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

4 August 2017

1122

1 reference

Europe PubMed Central

4 August 2017

155-168

1 reference

Europe PubMed Central

4 August 2017

Neurotrophins and neuronal differentiation in the central nervous system.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Recent progress in studies of neurotrophic factors and their clinical implications

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Neurotrophin signaling via Trks and p75.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Intracellular signaling pathways activated by neurotrophic factors

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Point source concentration of GDNF may explain failure of phase II clinical trial

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Rasagiline improves quality of life in patients with early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin-1 protects PC12 cells from injury: involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase pathways

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Synaptotagmin IV does not alter excitatory fast synaptic transmission or fusion pore kinetics in mammalian CNS neurons

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Effect of chronic treatment with ladostigil (TV-3326) on anxiogenic and depressive-like behaviour and on activity of the hypothalamic-pituitary-adrenal axis in male and female prenatally stressed rats

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1403.011

21 January 2018

Identifiers

10.1196/ANNALS.1403.011

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34725080&oldid=2103254127"